Sign In
Buy APLT
$0.0959
+0 (+0%)
At Close: Apr 28, 2026
Applied Therapeutics Reports First Quarter 2020 Financial Results
11:00am, Monday, 11'th May 2020
NEW YORK, May 11, 2020 -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated.
Apollo Commercial Real Estate Finance, Inc. (ARI) CEO Stuart Rothstein on Q1 2020 Results - Earnings Call Transcript
08:46pm, Friday, 08'th May 2020
Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI) Q1 2020 Earnings Conference Call May 08, 2020 09:00 AM ET Company Participants Stuart Rothstein - Chief E
6 Stock Charts to Watch: ADVM, AKBA, APLT, CLSK, OBSV, TGTX
12:00am, Wednesday, 06'th May 2020
Stocks Analysis by Harry Boxer covering: Seattle Genetics Inc, Winnebago Industries Inc, Chembio Diagnostics Inc, TG Therapeutics Inc. Read Harry Boxer's latest article on Investing.com
Short Interest in Applied Therapeutics (NASDAQ:APLT) Rises By 7.6%
06:14am, Friday, 01'st May 2020
Applied Therapeutics (NASDAQ:APLT) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 409,500 shares, an increase of 7.6% from the March
Bank of New York Mellon Corp Grows Position in Applied Therapeutics (NASDAQ:APLT)
09:24am, Tuesday, 28'th Apr 2020
Bank of New York Mellon Corp raised its holdings in Applied Therapeutics (NASDAQ:APLT) by 8.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
Goldman Sachs: 2 Stocks That Could Climb Over 60%
01:07pm, Monday, 27'th Apr 2020
When it comes to the current economic landscape, you can either look at the glass half empty or half full. Driven by positive developments in the re-opening of the global economy, U.S. stock futures p
G20 ministers discuss COVID-19 impact on tourism
06:01pm, Friday, 24'th Apr 2020
RIYADH: The Saudi G20 presidency on Friday held a virtual tourism ministers’ meeting to discuss the coronavirus pandemic and tourism. The ministers agreed to explore capacity programs in the industr
Applied Therapeutics Announces Full Data and Scientific Presentations from the Pivotal Phase 2 ACTION-Galactosemia Trial
11:00am, Tuesday, 21'st Apr 2020
Applied Therapeutics, Inc. (APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical ne
Applied Therapeutics (NASDAQ:APLT) Short Interest Down 19.1% in March
08:44am, Saturday, 18'th Apr 2020
Applied Therapeutics (NASDAQ:APLT) was the target of a significant decline in short interest during the month of March. As of March 31st, there was short interest totalling 380,400 shares, a decline o
Have Insiders Been Buying Applied Therapeutics, Inc. (NASDAQ:APLT) Shares This Year?
12:22pm, Saturday, 11'th Apr 2020
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
Applied Therapeutics (NASDAQ:APLT) Shares Up 9.9%
05:28am, Tuesday, 07'th Apr 2020
Applied Therapeutics (NASDAQ:APLT)’s stock price shot up 9.9% during trading on Monday . The stock traded as high as $35.48 and last traded at $35.01, 115,532 shares were traded during trading. A de
Applied Therapeutics (NASDAQ:APLT) Stock Rating Upgraded by ValuEngine
07:42am, Monday, 06'th Apr 2020
ValuEngine upgraded shares of Applied Therapeutics (NASDAQ:APLT) from a hold rating to a buy rating in a report released on Thursday, ValuEngine reports. A number of other equities analysts also recen
Citigroup Inc. Has $36,000 Position in Applied Therapeutics (NASDAQ:APLT)
08:42am, Sunday, 05'th Apr 2020
Citigroup Inc. increased its holdings in shares of Applied Therapeutics (NASDAQ:APLT) by 1,385.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exc
Applied Therapeutics (NASDAQ:APLT) Receives Consensus Rating of "Buy" from Analysts
06:16am, Sunday, 05'th Apr 2020
Applied Therapeutics (NASDAQ:APLT) has received a consensus rating of “Buy” from the eight ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the st
Here's a roundup of top developments in the biotech space over the last 24 hours.On a day when the three major averages shed over 4% in reaction to bleak forecasts concerning the COVID-19 pandemic's
